Virax Biolabs Corp (VRAX) Price to Earnings Ratio

Corporate emblem and logo of Virax Biolabs Group Ltd (VRAX)

The daily price action for Virax Biolabs Group (VRAX), which currently stands at -0.20, reflects stagnant profits driven by test kit distribution limits and fixed transportation costs. Virax Biolabs Group is implementing robotic systems for PCR diagnostics to eliminate routine operations for personnel. The automation of laboratory virus-detection processes enables rapid infection identification, significantly reducing the need for a large workforce.

VRAX Virax Biolabs: Price to Earnings Ratio in the range 09/25/2023 - 11/16/2026

Analytical breakdowns for Virax Biolabs Group

General company analysis:Virax Biolabs
Manufactured product of Virax Biolabs Group

The P/E ratio measures the investment payback period through the ratio of market capitalization to net income. Daily monitoring of the current P/E of Virax Biolabs Group (VRAX) allows for tracking market sentiment without quarterly delays. For Virax Biolabs Group (VRAX), stable sales of diagnostic panels support the denominator of this formula. Analysis of the current P/E trend confirms the business's ability to fund R&D from its own turnover. This indicates the fundamental maturity and financial stability of the issuer.

Key competitors

Agilent (A) - Business Payback Period|Price to Earnings Ratio DGX (questdiagnostics.com)|Price to Earnings Ratio ILMN (Illumina, Inc.)|Exact Sciences Corp - Price to Earnings Ratio|revvity.com (RVTY) - Market Cap to Earnings|Bio-Rad Laboratories, Inc. - P/E Multiple|Business Payback Period Anbio NNNN|Nordion (SHC) - Price to Earnings Ratio|QDEL - Business Payback Period|Price to Earnings Ratio OPKO Health Inc|CareDx (CDNA) - Business Payback Period|Price to Earnings Ratio Maravai LifeSciences Holdings (MRVI)|FLGT: Market Cap to Net Income|P/E Multiple LAB (Standard BioTools Inc)|Cytek Biosciences, Inc. (CTKB) - Market Cap to Earnings|OraSure Corp - P/E Multiple|Market Cap to Net Income Ratio exagen.com (XGN)|MDXH: P/E Multiple|LUCD - Business Payback Period|Price to Earnings Ratio PRE|IMDX - Market Cap to Net Income Ratio|Price to Earnings Ratio TRIB (Trinity Biotech plc)|P/E Multiple prophaselabs.com (PRPH)|P/E Multiple AIMD (Ainos Inc)|Market Cap to Net Income Ratio Co-Diagnostics Inc|heartsciences.com - P/E Multiple|Biomerica, Inc (BMRA) - Price to Earnings Ratio|CDIO: P/E Multiple|Price to Earnings Multiple ONCO|BJDX (Bluejay Diagnostics Inc) - P/E Multiple|Market Cap to Earnings Aspira Women's Health, Inc. AWH|Price to Earnings Ratio AXDX (Accelerate Diagnostics, Inc)|CENTOGENE, N.V. - Price to Earnings Multiple|Enzo Biochem, Inc. - Price to Earnings Ratio|FRES - Price to Earnings Ratio|GENE - Price to Earnings Ratio|Company Value to Net Income ME (23andMe)|PMD: P/E Multiple